Adherence interventions and outcomes of tuberculosis treatment: A systematic review and meta-analysis of trials and observational studies
Open accessThe DOI matches its Crossref record; 153 of the 156 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Incomplete adherence to tuberculosis (TB) treatment increases the risk of delayed culture conversion with continued transmission in the community, as well as treatment failure, relapse, and development or amplification of drug resistance. We conducted a systematic review and meta-analysis of adherence interventions, including directly observed therapy (DOT), to determine which approaches lead to improved TB treatment outcomes. METHODS AND FINDINGS: We systematically reviewed Medline as well as the references of published review articles for relevant studies of adherence to multidrug treatment of both drug-susceptible and drug-resistant TB through February 3, 2018. We included randomized controlled trials (RCTs) as well as prospective and retrospective cohort studies (CSs) with an internal or external control group that evaluated any adherence intervention and conducted a meta-analysis of their impact on TB treatment outcomes. Our search identified 7,729 articles, of which 129 met the inclusion criteria for quantitative analysis. Seven adherence categories were identified, including DOT offered by different providers and at various locations, reminders and tracers, incentives and enablers, patient education, digital technologies (short message services [SMSs] via mobile phones and video-observed therapy [VOT]), staff education, and combinations of these interventions. When compared with DOT alone, self-administered therapy (SAT) was associated with lower rates of treatment success (CS: risk ratio [RR] 0.81, 95% CI 0.73-0.89; RCT: RR 0.94, 95% CI 0.89-0.98), adherence (CS: RR 0.83, 95% CI 0.75-0.93), and sputum smear conversion (RCT: RR 0.92, 95% CI 0.87-0.98) as well as higher rates of development of drug resistance (CS: RR 4.19, 95% CI 2.34-7.49). When compared to DOT provided by healthcare providers, DOT provided by family members was associated with a lower rate of adherence (CS: RR 0.86, 95% CI 0.79-0.94). DOT delivery in the community versus at the clinic was associated with a higher rate of treatment success (CS: RR 1.08, 95% CI 1.01-1.15) and sputum conversion at the end of two months (CS: RR 1.05, 95% CI 1.02-1.08) as well as lower rates of treatment failure (CS: RR 0.56, 95% CI 0.33-0.95) and loss to follow-up (CS: RR 0.63, 95% CI 0.40-0.98). Medication monitors improved adherence and treatment success and VOT was comparable with DOT. SMS reminders led to a higher treatment completion rate in one RCT and were associated with higher rates of cure and sputum conversion when used in combination with medication monitors. TB treatment outcomes improved when patient education, healthcare provider education, incentives and enablers, psychological interventions, reminders and tracers, or mobile digital technologies were employed. Our findings are limited by the heterogeneity of the included studies and lack of standardized research methodology on adherence interventions. CONCLUSION: TB treatment outcomes are improved with the use of adherence interventions, such as patient education and counseling, incentives and enablers, psychological interventions, reminders and tracers, and digital health technologies. Trained healthcare providers as well as community delivery provides patient-centered DOT options that both enhance adherence and improve treatment outcomes as compared to unsupervised, SAT alone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



























Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The consequences of poor adherence include delayed sputum culture conversion, treatment failure, relapse, prolonged infectiousness, development of drug resistance, and increased morbidity and mortality [4,5].”
From Psychosocial Interventions for Improving Treatment Adherence in Tuberculosis Patients: A Scoping Review of Evidence-Based Approaches. (2026) · cites this paper as [4]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Previous research has indicated that treatment adherence interventions (eg, patient counselling and education, reminders, and digital health technologies)47, 48 and social protection interventions (eg, cash transfers and economic incentives)49, 50 can increase treatment adherence and prevent mortality.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
(2014) · Medical Entomology and Zoology · Cited by 17,633
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
Rothwell, P. M. (2005) · The Lancet · doi:10.1016/s0140-6736(04)17670-8 · Cited by 2,544
Free, C., Phillips, G., Galli, L., Watson, L., Felix, L., Edwards, P., Patel, V., & Haines, A. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001362 · Cited by 1,766 · cited 1×
“Psychological interventions aim to support via psychological or emotional counseling or a social network of peers undergoing TB treatment as a means of improving adherence to TB treatment [18,19].”
BackgroundNahid, P., Dorman, S. E., Alipanah, N., Barry, P. M., Brozek, J. L., Cattamanchi, A., Chaisson, L. H., Chaisson, R. E., Daley, C. L., Grzemska, M., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw376 · Cited by 1,170
Self-citationPatient Adherence to Tuberculosis Treatment: A Systematic Review of Qualitative Research
Munro, S. A., Lewin, S. A., Smith, H. J., Engel, M. E., Fretheim, A., & Volmink, J. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040238 · Cited by 1,080
Assessing the Gold Standard — Lessons from the History of RCTs
Bothwell, L. E., Greene, J. A., Podolsky, S. H., & Jones, D. S. (2016) · New England Journal of Medicine · doi:10.1056/nejmms1604593 · Cited by 664
Directly observed therapy for treating tuberculosis
Karumbi, J., & Garner, P. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003343.pub4 · Cited by 644
The Effect of Directly Observed Therapy on the Rates of Drug Resistance and Relapse in Tuberculosis
Weis, S. E., Slocum, P. C., Blais, F. X., King, B., Nunn, M., Matney, G. B., Gomez, E., & Foresman, B. H. (1994) · New England Journal of Medicine · doi:10.1056/nejm199404283301702 · Cited by 589 · cited 2×
“Only three CSs compared the impact of DOT on the development of drug resistance compared with SAT, one of which found no significant difference [4,59,70].”
BackgroundResultOrenstein, E. W., Basu, S., Shah, N. S., Andrews, J. R., Friedland, G. H., Moll, A. P., Gandhi, N. R., & Galvani, A. P. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70041-6 · Cited by 540
Research works printed but not linked: 7
- Alipanah N, Jarlsberg L, Miller C, Lechner A, Wai K, Nahid P. Report for Systematic Review for Adherence Interventions in TB Treatment. World Health Organization guidelines for treatment of drug-susceptible tuberculosis and patient care. 2017;Annex 5.
- Review Manager (RevMan). 5.3 ed Copenhagen: The Nordic Cochrane Centre: The Cochrane Collaboration; 2014.
- Vieira AA, Ribeiro SA. Compliance with tuberculosis treatment after the implementation of the directly observed treatment, short-course strategy in the city of Carapicuiba, Brazil. J Bras Pneumol. 2011; 37(2): 223– 31. Epub 2011/05/04.. 21537659
- Arora VK S N.; Gupta R. Community mediated domiciliary DOTS execution—A study from New Delhi. Ind J Tub. 2003; 50: 143– 50.
- Cantalice Filho JP. Food baskets given to tuberculosis patients at a primary health care clinic in the city of Duque de Caxias, Brazil: effect on treatment outcomes. J Bras Pneumol. 2009; 35(10): 992– 7. Epub 2009/11/18.. 19918632
- Paramasivan RP, R. T.; Rajasekaran S. Short course chemotherapy: A controlled study of indirect default retrieval method. Ind J Tub. 1993; 40: 185– 90.
- A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre. Int J Tuberc Lung Dis. 1997; 1(6): 509– 17. Epub 1998/03/06.. 9487448
Cited by
Items 201–300 of 503
Digital devices for tuberculosis treatment adherence
Vilyte, G., Fox, T., Rohwer, A. C., Volmink, J. A., & McCaul, M. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015709 · Cited by 8
Alarcón‐Braga, E. A., Salazar-Valdivia, F. E., Estrada-Grossmann, J. M., Méndez-Guerra, C., Pacheco-Barrios, N. V., & Al‐kassab‐Córdova, A. (2023) · American Journal of Infection Control · doi:10.1016/j.ajic.2023.12.001 · Cited by 10
Reddy, K. P., Horsburgh, C. R., Wood, R., Fields, N. F., Girouard, M. P., Costantini, S., Hou, T., Freedberg, K. A., & Walensky, R. P. (2019) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201905-418oc · Cited by 10
Brugueras, S., Roldán, L., Rodrigo, T., García-García, J.-M., Caylà, J. A., García-Pérez, F. J., Orcau, À., Viladrich, I. M., Penas-Truque, A., & Millet, J.-P. (2020) · Archivos de Bronconeumología · doi:10.1016/j.arbr.2019.12.002 · Cited by 6
The Benefits and Risks of Adherence to Medical Therapy
Scialli, A. R., Saavedra, K., & Fugh‐Berman, A. (2021) · The Journal of Scientific Practice and Integrity · doi:10.35122/001c.21386 · Cited by 6
Ruan, Y., Li, L., Xu, L., Zhao, Y., Li, Z., Xu, Z., Wang, K., Su, W., Li, R., & FHI 360 China Kunming Office, K. (2021) · China CDC Weekly · doi:10.46234/ccdcw2021.146 · Cited by 6
Giri, O. P., Kumar, A., Giri, V. P., & Nikhil, N. (2022) · Cureus · doi:10.7759/cureus.22886 · Cited by 6
Brugueras, S., Roldán, L., Rodrigo, T., García-García, J.-M., Caylà, J. A., García-Pérez, F. J., Orcau, À., Viladrich, I. M., Penas-Truque, A., & Millet, J.-P. (2019) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2019.04.013 · Cited by 6
Krishnamoorthy, Y., Selvaraja, C., & Govindan, D. (2025) · Clinical Epidemiology and Global Health · doi:10.1016/j.cegh.2025.102123 · Cited by 5
Filho, F. G. S. D. S., Falcão, I. W. S., de Souza, T. M., Carneiro, S. R., Seruffo, M. C. D. R., & Cardoso, D. L. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14248646 · Cited by 8
“The systematic review by Alipanah et al. (2018) published in PLoS Medicine demonstrated that structured training programs for healthcare providers improved patient treatment completion rates by 12–20% while reducing treatment abandonment by 8–15% [16].”
Chiaranai, C., Chularee, S., Prawatwong, W., & Srithongluang, S. (2023) · Pacific Rim International Journal of Nursing Research · doi:10.60099/prijnr.2023.262244 · Cited by 12
Rianto, L., Agustina, I., Alfian, S. D., Iskandarsyah, A., Pradipta, I. S., & Abdulah, R. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1257353 · Cited by 22
Tuberculosis and labour market participation: Evidence from South Africa
Ting, H., Bozzola, M., & Ravetti, C. (2024) · South African Journal of Economics · doi:10.1111/saje.12385 · Cited by 5
“…that a patient successfully completes the full course of the TB treatment include methods based on providing comprehensive and personalised support (Alipanah et al., 2018) and digital approaches such as interactive two-way mobile phone text message reminders and video assisted DOT (Ngwatu et al.,…”
MethodTaking the Big Leap | understanding, accessing and improving behavioural science interventions
Gantayat, N., Ashok, A., Manchi, P., Pierce-Messick, R., Porwal, R., & Gangaramany, A. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1355539 · Cited by 7
Barik, A. L., Indarwati, R., & Sulistiawati, S. (2020) · STRADA JURNAL ILMIAH KESEHATAN · doi:10.30994/sjik.v9i2.381 · Cited by 5
“The impact is that it results in increased transmission in the community, increased treatment costs, and an increase in the number of TB-MDR (Multi-Drug Resistant) cases(Alipanah et al., 2018).”
BackgroundTersigni, C., Boiardi, G., Tofani, L., Venturini, E., Montagnani, C., Bortone, B., Bianchi, L., Chiappini, E., Cassetta, M. I., Fallani, S., et al. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06764-7 · Cited by 6
Dodd, M., Carpenter, J. R., Thompson, J. A., Williamson, E., Fielding, K., & Elbourne, D. R. (2024) · Statistics in Medicine · doi:10.1002/sim.10067 · Cited by 7
“29,30 31-33 Our findings are also of interest beyond TB trials, where non-adherence to treatment is likely to remain a concern for the foreseeable future.”
BackgroundKerschberger, B., Daka, M., Shongwe, B., Dlamini, T., Ngwenya, S., Danbakli, C., Mamba, B. B., Nxumalo, B., Sibanda, J., Dube, S., et al. (2024) · BMC Health Services Research · doi:10.1186/s12913-024-11151-4 · Cited by 5
“…has been mainly piloted in high-income countries and increased the proportion of verified prescribed doses taken, appeared to be programmatically feasible and cost-effective, and was acceptable to health workers and patients, while treat-ment outcomes remained similar to in-person DOT [10, 14–20].”
BackgroundMethodResultInfluentialNagaraja, S. B., Kotur, N. S., Murthy, N., Kunjathur, S. M., Sappandi, N. B., Murthy, D., Das, A., & Singarajipur, A. (2020) · Journal of Tuberculosis Research · doi:10.4236/jtr.2020.81001 · Cited by 5
“Several studies have shown that electronic reminders improve adherence to chronic medication [8].”
BackgroundWijayanti, E., Bachtiar, A., Achadi, A., Rachmawati, U. A., Sjaaf, A. C., Eryando, T., Besral, B., Trihono, Siregar, K. N., & Vidiawati, D. (2022) · PLoS ONE · doi:10.1371/journal.pone.0272616 · Cited by 9
“Studies suggest adherence interventions for improving outcomes, such as medication event reminder monitor (MERM) systems, electronic pillboxes, and text messaging [10, 11].”
BackgroundShihora, J., Damor, N. C., Parmar, A. J., Pankaj, N., & Yogesh, M. (2024) · Cureus · doi:10.7759/cureus.56368 · Cited by 5
Daramola, O., & Nyasulu, P. S. (2019) · Open Innovations Conference (OI) · doi:10.1109/oi.2019.8908213 · Cited by 5
“Empirical evidence show that improved patient’s treatment outcome is proportional to good medication adherence [1].”
BackgroundMunteanu, I., Kalambayi, F., Toth, A., Dendrino, D., Burdusel, B., Vlasceanu, S.-G., Parliteanu, O., Dragomir, A., Nemes, R. M., & Mahler, B. (2025) · Applied Sciences · doi:10.3390/app15158173 · Cited by 4
Ballif, M., Banholzer, N., Perrig, L., Avihingsanon, A., Nsonde, D., Obatsa, S., Muula, G. K., Komena, E., Uemura, H., Lelo, P. V. M., et al. (2025) · BMJ Global Health · doi:10.1136/bmjgh-2024-017828 · Cited by 8
Ryskulov, G., Adenov, M. M., Zhaparkulova, M., Bissembayev, A., Rakhimbekova, G., Tanabayeva, D., Tanabayeva, S. B., Fakhradiyev, I., & Едигеевич, Ш. М. (2026) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed11030075 · Cited by 4
“Strengthening adherence support, early detection of relapse, and focused follow-up of high-risk patients may yield further improvements in treatment outcomes [24].”
Rissaadah, S., Nursiswati, N., & Pahria, T. (2025) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s510247 · Cited by 7
Educational technologies to guide pulmonary tuberculosis sputum collection: a systematic review
da Silva, K. N., dos Santos, P. S. P., Barbosa, R. D. S., Lopes, M. D. S. V., Pinto, A. G. A., & Cavalcante, E. G. R. (2022) · Revista da Escola de Enfermagem da USP · doi:10.1590/1980-220x-reeusp-2021-0433en · Cited by 4
“In fact, implementation according to local resources and the needs of RS people with TB facilitates adherence to the recommendations(24).”
BackgroundEmergence of phenotypic and genotypic antimicrobial resistance in Mycobacterium tuberculosis
Kloprogge, F., Canseco, J. O., Phee, L. M., Sadouki, Z., Kipper, K., Witney, A. A., Stoker, N. G., & McHugh, T. D. (2022) · Scientific Reports · doi:10.1038/s41598-022-25827-6 · Cited by 5
Hudson, M., Todd, H., Nalugwa, T., Boccia, D., Wingfield, T., & Shete, P. B. (2023) · Wellcome Open Research · doi:10.12688/wellcomeopenres.18807.1 · Cited by 4
Sunpapoa, C., Na-Ek, N., Sommai, A., Boonpattharatthiti, K., Huynh, N. S., & Kanchanasurakit, S. (2023) · Asian Nursing Research · doi:10.1016/j.anr.2023.06.002 · Cited by 4
Kim, H., Song, E.-J., Choi, E., Kwon, K. W., Park, J., & Shin, S. J. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.111937 · Cited by 4
Farley, J. E., Ndjeka, N. O., Mlandu, K., Lowensen, K., Geiger, K., Nguyen, Y. T.-K., Budhathoki, C. B., & Stamper, P. D. (2021) · Human Resources for Health · doi:10.1186/s12960-020-00552-1 · Cited by 4
Xin, H., Zhang, H., Wang, D., Zhang, B., Cao, X., Feng, B., Quan, Z., Du, Y., He, Y., Guan, L., et al. (2021) · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · doi:10.1016/j.jctube.2021.100266 · Cited by 4
“TB treatment outcomes improved when patient education, healthcare provider education, reminders and tracers, or mobile digital technologies were employed [17].”
BackgroundConsequences of Nonadherence and Correlates of Adherence
Rapoff, M. A., Duncan, C. L., & Karlson, C. (2023) · Issues in clinical child psychology · doi:10.1007/978-3-031-27484-8_2 · Cited by 5
Jiang, S., Li, X., Fu, M., Huanglu, D., Huang, J., Huang, W. M., & Hu, P. (2023) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-023-01584-y · Cited by 4
Kim, M., Bhattacharya, J., & Bhattacharya, J. (2024) · Social Science & Medicine · doi:10.1016/j.socscimed.2024.116639 · Cited by 8
Faye, L. M., Hosu, M. C., Dlatu, N., Iruedo, J., & Apalata, T. R. (2025) · Frontiers in Tuberculosis · doi:10.3389/ftubr.2025.1659333 · Cited by 4
Adisa, R., & Durojaye, D. M. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-099559 · Cited by 6
“27 28 31 WHO has defined social support as the amount of perceived and practical care received from family, friends and/or the community.”
Troop, P., Keam, B., Mullen, C., & Odhiambo, J. N. (2026) · PLoS ONE · doi:10.1371/journal.pone.0340307 · Cited by 3
Park, H., Kwon, J., Kim, H., Kwon, S., Nam, J. H., Min, S., Oh, I., Bea, S., & Choi, S. H. (2023) · Journal of Korean Medical Science · doi:10.3346/jkms.2023.38.e167 · Cited by 4
Fuadiati, L. L., Sukartini, T., Makhfudli, M., Dewi, Y. S., Rosyid, A. N., & Qona’ah, A. (2024) · International Journal of Public Health Science (IJPHS) · doi:10.11591/ijphs.v13i1.23309 · Cited by 4
“In other words, health education interventions, patient counseling, and material support can increase knowledge and medication adherence in tuberculosis patients undergoing treatment [27].”
BackgroundShah, H., Yasobant, S., Patel, J., Bhavsar, P., Saha, S., Patel, Y., Saxena, D. B., & Sinha, A. K. (2024) · F1000Research · doi:10.12688/f1000research.125815.2 · Cited by 3
Adherence to treatment in pulmonary tuberculosis: Rodgers’ evolutionary concept analysis
Prasetyo, Y. A., Thanasilp, S., & Preechawong, S. (2024) · Belitung Nursing Journal · doi:10.33546/bnj.3416 · Cited by 7
“Enhanced Efficacy of TB Treatment Being Cured (Tesfahuneygn et al., 2015), (Alipanah et al., 2018), (Vernon et al., 2019), (Nezenega et al., 2020) Increased Commitment to Adhere Prevention of Relapse (Alipanah et al., 2018), (Gashu et al., 2021), (Zong et al., 2018), (Mamo et al., 2021) Reduced Mortality Rate (Kayigam…”
BackgroundInfluentialA Multi Center, Epidemiological Study of Bone Tuberculosis in Southwest China from 2011 to 2023
Qin, X., Qin, B., Zhou, C., Liu, C., Chen, T., Zhu, J., Huang, C., Wu, S., He, R., Wu, S., et al. (2024) · Journal of Epidemiology and Global Health · doi:10.1007/s44197-024-00325-2 · Cited by 5
Permana, R., Afrizal, A., Yunus, F., & Bachtiar, A. (2025) · The Open Public Health Journal · doi:10.2174/0118749445365074250103103825 · Cited by 3
Turyahabwe, S., Ramachandra, S. S., Quraishi, S., Fasih, I., Quraishi, H., Peddapalegani, P., & Ahmad, A. (2025) · PLoS ONE · doi:10.1371/journal.pone.0318174 · Cited by 3
Adejumo, O. A., Daniel, O. J., Jinabhai, C. C., & Haffejee, F. (2025) · International Journal of Mycobacteriology · doi:10.4103/ijmy.ijmy_209_24 · Cited by 8
Shi, L., Zhang, J., & Deng, Y. (2025) · BMC Medicine · doi:10.1186/s12916-025-04128-5 · Cited by 4
“Previous studies focusing on chronic diseases that require long-term home medication, such as HIV/AIDS and tuberculosis, have found a close correlation between emotion and treatment adherence [12, 13], and relevant intervention measures have been developed to successfully improve adherence [13, 14].”
Adherence to oral antibiotic therapy in patients with bone and joint infection: A pilot study
Lalande, L., Bretagnolle, C., Mabrut, E., Ferry, T., & Goutelle, S. (2021) · Infectious Diseases Now · doi:10.1016/j.idnow.2020.10.007 · Cited by 3
Julhana, Dramawan, A., Haris, A. R., & Syaiful (2021) · Medico-Legal Update · doi:10.37506/mlu.v21i2.2762 · Cited by 3
Pinargote-Chancay, R.-D.-R. (2023) · Revista Arbitrada Interdisciplinaria de Ciencias de la Salud Salud y Vida · doi:10.35381/s.v.v7i14.2567 · Cited by 7
Tuberculosis in children and adolescents: a forgotten group in a forgotten disease
López‐Varela, E., Munyangaju, I., Chabala, C., Sekadde, M. P., & Seddon, J. A. (2023) · European Respiratory Society eBooks · doi:10.1183/2312508x.10025322 · Cited by 3
Chijioke-Akaniro, O., Akinyemi, P. A., Asuke, S., Anyaike, C., Uwaezuoke, N. A., Ochuko, U., Ubochioma, E., Omoniyi, A., Merle, C. S., & Daniel, S. (2023) · International Health · doi:10.1093/inthealth/ihad104 · Cited by 3
Polypill and Combination Therapy: Blood Pressure and Cardiovascular Risk Reduction
Park, J., Yang, C.-W., Huan, Y., & Aggarwal, S. (2023) · Current Cardiology Reports · doi:10.1007/s11886-023-02000-7 · Cited by 4
“Studies have shown that interventions to improve adherence include education and counseling, incentives and enablers, psychological interventions, reminders and tracers, digital health technologies, and bio-chemical screening (i.e., urine analysis) [44, 45].”
Li, J., Zhang, R., Yang, G., Cai, Q., Lang, Y., Zhong, F., Huang, J., Chen, Y., Yao, Q., Fang, L., et al. (2024) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.16050 · Cited by 3
“16 Nonadherence has also been reported as 1 of the most important factors associated with the emergence of acquired drug resistance.”
Unit costs and cost-effectiveness of a device to improve TB treatment adherence in China
Sweeney, S., Fielding, K., Liu, X., Thompson, J. A., Dong, H., Jiang, S., Zhao, Y., Huan, S., & Vassall, A. (2024) · IJTLD OPEN · doi:10.5588/ijtldopen.23.0451 · Cited by 6
“5 6–9 Some studies have shown that medication reminders, combined with efforts to improve adherence, can significantly enhance treatment outcomes, 10–12 suggesting that implementation strategies may influence impact.”
BackgroundWang, X., Song, Y., Li, N., Huo, J., Wang, B., Jiang, X., & Zhang, Y. (2025) · International Journal of General Medicine · doi:10.2147/ijgm.s502996 · Cited by 3
“33 In addition, when humoral immunity is reduced, the body’s immune pressure against pathogens is weakened, making it easier for pathogens to survive and multiply in the body.”
Calixte, D., Morris, S. M., Toussaint, E., Fénelon, D. L., Banigbe, B., & Kwan, G. F. (2025) · PLOS Global Public Health · doi:10.1371/journal.pgph.0004376 · Cited by 4
Sahile, Z., Perimal‐Lewis, L., Arbon, P., & Maeder, A. J. (2021) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 3
Determinants of tuberculosis treatment outcomes in Asia and Africa
Yuliyani, Y., & Sartika, R. A. D. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6n1.1666 · Cited by 2
COVID-19: Current Challenges and Future Perspectives
Leggat, P., Frean, J., & Blumberg, L. (2022) · MDPI eBooks · doi:10.3390/books978-3-0365-3119-9 · Cited by 4
Sousa, E. D. O., Carneiro, R. T. D. O., Montes, F. C. O. F., Conceição, E. C., Bartholomay, P., Marinho, J. M., Lima, K. V. B., Natividade, M., de Araújo, W. N., Matos, E. D., et al. (2022) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/0037-8682-0013-2022 · Cited by 3
“Erivelton de Oliveira Sousa[1],[2]*, Rita Terezinha de Oliveira Carneiro[2]*, Fátima Cristina Onofre Fandinho Montes[3] , Emilyn Costa Conceição[4] , Patricia Bartholomay[5] , Jamocyr Moura Marinho[6] , Karla Valéria Batista Lima[7] , Marcio Santos da Natividade[8] , Wildo Navegantes de Araújo[5] , Eliana Dia…”
BackgroundKesenogile, B., Godman, B., & Rwegerera, G. M. (2020) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2020.1822735 · Cited by 3
Short-duration treatment for latent tuberculosis in migrants: VDOT monitoring in Manaus, AM.
Alves, Y. M., de Jezus, S. V., Berra, T. Z., Araújo, V. M. S., Maciel, E. L. N., & Arcêncio, R. A. (2024) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/0037-8682-0530-2023 · Cited by 3
Barreto‐Duarte, B., Villalva-Serra, K., Miguez-Pinto, J. P., Araújo‐Pereira, M., Campos, V. M. S., Rosier, G. L., Nogueira, B. M. F., Queiroz, A. T. L., Rolla, V. C., Cordeiro‐Santos, M., et al. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4654261 · Cited by 3
Jomidava, T., Khogali, M. A., Sereda, Y., Avaliani, Z., Davitashvili, M., Madzgharashvili, M., Tukvadze, N., Chaphurishvili, L., Chincharauli, M., & Kipiani, M. (2021) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.13783 · Cited by 2
“While some studies found that provision of educational and psychosocial support to drug-resistant TB patients was associated with an increased adherence to treatment and subsequent improvement in treatment outcomes [12,15], other studies reported no effect on treatment outcomes despite the increase in adherence [9].”
BackgroundInfluentialO tratamento da Tuberculose na atenção primária à saúde sob contexto da pandemia COVID-19
Takahashi, E. M., de Souza, K. L., Ribeiro, S., Yamamoto, T. T., Gonzáles, R. I. C., Fernandes, H., Hino, P., & Caldas, J. M. P. (2024) · Contribuciones a las Ciencias Sociales · doi:10.55905/revconv.17n.1-294 · Cited by 2
Santos, V. S., de Holanda, J. R. C., Neto, R. D. S. G., Maciel, E. L. N., Johansen, F. D. C., Júnior, J. N. D. B. S., Coelho, W. A. C., Silva, J. R. L. E., Silva, J. R. S., Gurgel, R. Q., et al. (2024) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2024.100938 · Cited by 3
Mwanzui, F. M., Karanja, S. M., Muriithi, A. K., & Weyenga, H. (2025) · PLOS Global Public Health · doi:10.1371/journal.pgph.0004131 · Cited by 2
“However, a descriptive study in India reported a weaker association with HIV [9].”
InfluentialIribarren, S., Vidrio, O. A. A., Roberti, J. E., Goodwin, K., Chirico, C., Telles, H., Lutz, B. R., Bornengo, F., & Rubinstein, F. (2025) · Journal of Medical Internet Research · doi:10.2196/76742 · Cited by 3
“Despite free access to TB treatment, the lack of ongoing supervision and support contributes to poor adherence, undermining treatment success, and increasing the risk of resistance and transmission [11,12].”
Gwalani, R., Shah, H., Saxena, D. B., Patel, J., Baliyan, S., Thakur, J., Rai, S., Sen, M. A., & Yadav, A. (2025) · Indian Journal of Tuberculosis · doi:10.1016/j.ijtb.2025.06.019 · Cited by 2
Maulana, S., Lutfian, L., Wardika, I. J., Fadhli, R., Anggreani, D., Haposan, J. H., Wildana, F., Efendi, M., Platini, H., & Haroen, H. (2025) · Patient Preference and Adherence · doi:10.2147/ppa.s520341 · Cited by 6
“4,8 However, the volume and characteristics of studies specifically focused on TB medication adherence in Southeast Asia have not yet been systematically assessed.”
Factors associated with initial medication adherence with first-line therapy for depression.
Ganna, S., Li, J.-N., & Aparasu, R. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.120004 · Cited by 3
Agyapong, C. A., Parsa, A. D., Hayhoe, R. P. G., Kabir, R., & Cortnage, M. (2025) · Public Health Challenges · doi:10.1002/puh2.70108 · Cited by 2
Guseva, V., Vasilyeva, I. A., & Testov, V. V. (2025) · Tuberculosis and lung diseases · doi:10.58838/2075-1230-2025-103-4-8-23 · Cited by 2
Goshiye, S. M., Dube, L., Mogas, S. B., & Marine, B. T. (2025) · Health Science Reports · doi:10.1002/hsr2.71408 · Cited by 2
Kavyadharshni, B. B., Duraisamy, S. A., Garg, C., Seenivasan, P., & Asirvatham, E. S. (2025) · Clinical Epidemiology and Global Health · doi:10.1016/j.cegh.2025.102271 · Cited by 2
Soeroto, A. Y., Purwiga, A., Suryadinata, H., Alisjahbana, B., Makmun, A., Supriatna, Y. A., Pranggono, E. H., & Lestari, B. W. (2026) · PLoS ONE · doi:10.1371/journal.pone.0345702 · Cited by 2
“Non-adherence causes treatment failure, severe disease, prolonged hospitalization, increased treatment costs, and increased risk of drug resistance, making it crucial to recognize factors associated with treatment adherence [27].”
Duan, Y., Liu, J., Lin, S., Li, X., Luo, D., & Zhu, L. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1840258 · Cited by 2
“A 2018 meta-analysis reported that digital health intervention improved compliance and treatment success rates in tuberculosis treatment (16).”
Sahile, Z., Perimal-Lewis, L., Arbon, P., & Maeder, A. J. (2021) · PLoS ONE · doi:10.1371/journal.pone.0261758 · Cited by 5
Addressing bedaquiline treatment interruptions in the treatment of drug-resistant TB
Kambili, C., Rossenu, S., Hoetelmans, R. M. W., Birmingham, E., & Bakare, N. (2022) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.21.0678 · Cited by 2
Shah, H., Yasobant, S., Patel, J., Bhavsar, P., Saha, S., Patel, Y., Saxena, D. B., & Sinha, A. K. (2022) · F1000Research · doi:10.12688/f1000research.125815.1 · Cited by 2
Factors Associated with Treatment Adherence among Tuberculosis Patients in Gandaki Province of Nepal
Yadav, R. K., Kaphle, H. P., Yadav, D. K., Gurung, S. C., Khatri, E., & Baral, S. (2020) · SAARC Journal of Tuberculosis Lung Diseases and HIV/AIDS · doi:10.3126/saarctb.v18i1.34128 · Cited by 2
Kızıltaş, Ş., & Babalık, A. (2023) · Springer eBooks · doi:10.1007/978-3-031-22483-6_40-1 · Cited by 2
Grace, M., Ntale, M., Robert, S., Moses, J., Mukonzo, J., Mafigiri, D. K., Mubiri, P., & Bbosa, G. S. (2023) · African Health Sciences · doi:10.4314/ahs.v23i4.5 · Cited by 2
Appraising perception, accessibility and uptake of DAT among patients with TB
Ogbudebe, C. L., Odume, B. B., Gordon, I., Chukwuogo, O., Nwokoye, N. N., Useni, S., Efo, E., Gidado, M., Aniwada, E., Ihesie, A., et al. (2024) · Public Health Action · doi:10.5588/pha.24.0009 · Cited by 2
“12,13 The WHO has ensured adherence as a principal component of global ‘End TB Strategy’.”
BackgroundAntimycobacterial compounds produced by forest fungi: An overview
Meskini, M., Rami, M. R., & Ghosh, S. B. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18870-1.00027-5 · Cited by 2
Harrison, R. E., Shyleika, V., Vishneuski, R., Leonovich, O., Ветушко, Д. А., Skrahina, A. M., Mar, H. T., Garsevanidze, E., Falkenstein, C., Sayakci, Ö., et al. (2024) · International Health · doi:10.1093/inthealth/ihae066 · Cited by 6
SMS reminders for monitoring tuberculosis treatment among women in Greater Accra region, Ghana
Badzi, C. D., Kotoh, A. M., Tabong, P. T., Maya, E. T., Torpey, K., Kwara, A., Lartey, M. Y., & Adanu, R. (2024) · Digital Health · doi:10.1177/20552076241297746 · Cited by 5
Meiyanti, M., Bachtiar, A., Kusumaratna, R. K., Alfiyyah, A., Machrumnizar, M., & Pusparini, P. (2024) · Narra J · doi:10.52225/narra.v4i3.1660 · Cited by 2
Eyawo, O., Lyzwinski, L. N., Ugoji, U. C., Pan, S., Sorkpor, S. K., Tawari-Fufeyin, P., & Hogg, R. S. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-089507 · Cited by 3
Arlinda, D., Indah, R. M., Yulianto, A., Harso, A. D., Syarif, A. K., & Karyana, M. (2020) · Jurnal Penelitian dan Pengembangan Pelayanan Kesehatan · doi:10.22435/jpppk.v4i2.3698 · Cited by 2
“Resistance to at least 1 antiTB drug Resistant 48 6,2 17 37,0 31 4,2 0,001 22,43 (7,6-65,8) 9,48 (2,6-34,0)”
Threats and Interventions During the Treatment of Tuberculosis in an Inner-city District
Jové, N., Masdeu, E., Brugueras, S., Millet, J.-P., Ospina, J. E., Orcau, À., Rius, C., Caylà, J. A., & Sánchez, F. (2021) · Archivos de Bronconeumología · doi:10.1016/j.arbr.2020.05.016 · Cited by 2
Holmes, R. H., Sun, S., Kazi, S., Ranganathan, S., Tosif, S., Graham, S. M., & Graham, H. (2022) · PLoS ONE · doi:10.1371/journal.pone.0275789 · Cited by 2
“Many of these same factors are identified in the much larger literature on TB treatment adherence, where strategies such as patient education and counselling, incentives, reminders, psychological interventions, and digital health technologies can improve patient outcomes [15].”
BackgroundOtero, L., Zetola, N. M., Campos, M. A. L., Zunt, J. R., Bayer, A. M., Curisinche-Rojas, M., Ochoa, T. J., Reyes, M., Vega, V., der Stuyft, P. V., et al. (2023) · Trials · doi:10.1186/s13063-022-07062-6 · Cited by 3
Karasz, A., Merchant, K., Arnsten, J. H., Feinberg, J., Kim, A. Y., Lum, P. J., McKee, M. D., Mehta, S. H., Meißner, P., Norton, B. L., et al. (2023) · Journal of Medical Internet Research · doi:10.2196/38176 · Cited by 2
“Consequently, most research to date has examined VOT in the context of patients with tuberculosis [19-23].”
Marks, G. B., Teo, A. K. J., Wong, E. B., Fox, G. J., & Nguyen, T. A. (2023) · European Respiratory Society eBooks · doi:10.1183/2312508x.10023822 · Cited by 2
Towards the Design of a Gamified Application to Increase Tuberculosis Treatment Adherence in Vietnam
Wortberg, A., Perscheid, G., Moormann, J., & Vo, L. N. (2023) · Hawaii International Conference on System Sciences (HICSS) · doi:10.24251/hicss.2023.387 · Cited by 2
Bhattacharya, J., Bhattacharya, J., & Kim, M. (2023) · National Bureau of Economic Research · doi:10.3386/w31053 · Cited by 5
Multi‐target Compounds for Tuberculosis
Stelitano, G., Cocorullo, M., & Chiarelli, L. R. (2024) · Wiley eBooks · doi:10.1002/9781394182862.ch28 · Cited by 2
Metadata
- Authors
- Alipanah, N., Jarlsberg, L., Miller, C., Linh, N. N., Falzon, D., Jaramillo, E., & Nahid, P.
- Affiliations
- University of California, San Francisco (US)
- World Health Organization (CH)
- Corresponding author
- Nahid, Payam
- Venue
- PLOS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2018-07-03
- Volume
- 15
- Issue
- 7
- Pages
- e1002595
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC6029765
- OpenAlex
- W2810683857
- Cited by
- 503
- References
- 156
- Citations by year
- 2026: 48 · 2025: 75 · 2024: 79 · 2023: 88 · 2022: 75 · 2021: 67 · 2020: 42 · 2019: 26 · 2018: 3
- FWCI
- 5.09
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (publishedVersion)
- eScholarship (California Digital Library) (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Figshare (submittedVersion, cc-by)
- Funders
- World Health Organization
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
- Keywords
- tuberculosis, medication adherence, directly observed therapy, drug-resistant tuberculosis, self-administered therapy, sputum smear conversion, treatment failure, drug resistance development, incentives, patient education, video-observed therapy, mobile phone reminders, treatment success, relapse, transmission risk, multidrug therapy, patient-provider relationship
- MeSH terms
- Adolescent, Adult, Antitubercular Agents, Attitude of Health Personnel, Child, Child, Preschool, Health Personnel, Humans, Infant, Infant, Newborn, Health Knowledge, Attitudes, Practice, Patient Education as Topic, Risk Factors, Self Care, Tuberculosis, Video Recording, Randomized Controlled Trials as Topic, Treatment Outcome, Telemedicine, Directly Observed Therapy, Cell Phone, Medication Adherence, Text Messaging, Observational Studies as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.